Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist Lu-177-DOTAGA-PEG(2)-RM26

Authors :: Mitran, B
Rinne, SS
Konijnenberg, Mark
Maina, T
Nock, Berthold
Altai, M
Vorobyeva, A
Larhed, M
Tolmachev, V
Jong, Marion
Rosenstr?m, U
Orlova, A
Mitran, B
Rinne, SS
Konijnenberg, Mark
Maina, T
Nock, Berthold
Altai, M
Vorobyeva, A
Larhed, M
Tolmachev, V
Jong, Marion
Rosenstr?m, U
Orlova, A
Source :: Mitran , B , Rinne , SS , Konijnenberg , M , Maina , T , Nock , B , Altai , M , Vorobyeva , A , Larhed , M , Tolmachev , V , Jong , M , Rosenstr?m , U & Orlova , A 2019 , ' Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist Lu-177-DOTAGA-PEG(2)-RM26 ' , International Journal of Cancer , vol. 145 , no. 12 , pp. 3347-3358 .
Publication Year :: 2019

Database :: OAIster
Journal :: Mitran , B , Rinne , SS , Konijnenberg , M , Maina , T , Nock , B , Altai , M , Vorobyeva , A , Larhed , M , Tolmachev , V , Jong , M , Rosenstr?m , U & Orlova , A 2019 , ' Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist Lu-177-DOTAGA-PEG(2)-RM26 ' , International Journal of Cancer , vol. 145 , no. 12 , pp. 3347-3358 .
Notes :: application/pdf, und
Publication Type :: Electronic Resource
Accession number :: edsoai.on1313626805
Document Type :: Electronic Resource

Tools